Patient-centric performance and interpretation of positron emission tomography /computed tomography myocardial perfusion imaging: a clinical consensus statement of the European Association of Cardiovascular Imaging of the European Society of Cardiology
- PMID: 41536929
- PMCID: PMC12798802
- DOI: 10.1093/ehjimp/qyaf157
Patient-centric performance and interpretation of positron emission tomography /computed tomography myocardial perfusion imaging: a clinical consensus statement of the European Association of Cardiovascular Imaging of the European Society of Cardiology
Abstract
Positron emission tomography (PET) is the most advanced myocardial perfusion (MPI) technique for the non-invasive assessment of coronary artery disease and its many manifestations, including ischaemia, hibernation, and scar. This comprehensive overview aims to empower clinicians, technicians, and patients with clear, structured knowledge on performing and interpreting PET MPI. This document will describe stress protocols, patient preparation, tracer pharmacodynamics and nuclear properties, camera capabilities, post-acquisition processing, and a comprehensive and clear reporting system for both perfusion and viability imaging.
Keywords: cardiac stress testing; positron emission tomography myocardial perfusion; viability imaging.
© The European Society of Cardiology 2026.
Conflict of interest statement
Conflict of interest: A.A.G. reports research grant support from GE Healthcare, the Iten-Kohaut Foundation, and Promedica Stiftung, has given talks for GE Healthcare and has performed consultancy for Artrya Ltd. F.H. has received consultant and speaker fees from Bracco Imaging, Cisbio International, and GE healthcare, and he is a shareholder in Naogen Pharma. A.S. has received fees for lectures or consultancy from Abbot, Astra Zeneca, BMS, Janssen, Novo Nordisk, and Pfizer. W.A.J. is on the board of directors of the executive council of the American Society of Nuclear Cardiology. The remainder authors have no relevant disclosures.
Figures
References
-
- Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J 2024;45:3415–537. - PubMed
-
- Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation 2021;144:e368–454. - PubMed
-
- Multimodality Writing Group for Chronic Coronary Disease; Winchester DE, Maron DJ, Blankstein R, Chang IC, Kirtane AJ et al. ACC/AHA/ASE/ASNC/ASPC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2023 multimodality appropriate use criteria for the detection and risk assessment of chronic coronary disease. J Am Coll Cardiol 2023;81:2445–67. - PubMed
-
- Abadie B, Liga R, Buechel R, Giannopoulos AA, Pizzi MN, Roque A et al. Patient centric performance and interpretation of SPECT and SPECT/CT myocardial perfusion imaging: a clinical consensus statement of the European Association of Cardiovascular Imaging of the ESC. Eur Heart J Imaging Methods Pract 2025;3:345. - PMC - PubMed
-
- Renaud JM, Yip K, Guimond J, Trottier M, Pibarot P, Turcotte E et al. Characterization of 3-dimensional PET systems for accurate quantification of myocardial blood flow. J Nucl Med 2017;58:103–9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources